The symposium will provide a unique platform for cross-collaboration and discussion between industry, public sector, academia and regulators and focus on the latest thinking and opportunities arising from the new Biological Medicines. The goal is to identify potential solutions, future work programmes and productive collaborations that overcome the key regulatory challenges and facilitate accelerated access to safe and effective biologicals.​There will also be the opportunity to pose questions, participate in technical discussions and to network with peers. The symposium networking dinner (included in ticket prices) will be held on the evening of the 17 May 2016.
Biologicals represent some of the most important new medicines. They improve global health by preventing or providing novel treatments for the full spectrum of disease. With continued advancements in medical research and medical technology, the biological medicines sector face new challenges - not just scientific and regulatory.
The National Institute for Biological Standards and Control (NIBSC) is a global leader in the field of biological standardisation. It is responsible for developing and producing over 90% of the International Standards in use around the world that assure the quality of biological medicines. Our challenge for the 21st Century is to encourage and support innovation of biological products, whilst, at the same time, ensuring high levels of safety and quality.
NIBSC will continue its rich tradition of melding strong scientific research, with shaping innovative regulation that ensure timely access to safe and effective biological products.
The event will be held at The Royal College of Obstetricians and Gynaecologists
Learn about the latest strategic and technical developments taking place in biological medicines and gain insight into the regulatory challenge that they pose
Network and take the opportunity to meet key contacts, build relationships and initiate collaborations
Help shape the future of the new biological medicines regulation.
Molecular pathology and precision medicines: the importance of getting it right!
Keeping the vaccine pipeline open: high quality products at affordable prices
Advanced therapies: delivering the promise.
The symposium will bring together world class leaders from:
Biologics manufacturers
Academics and Innovators
National and International Regulators and public health organisations
Policy makers and funding agencies.
Biologicals represent some of the most important new medicines. They improve global health by preventing or providing novel treatments for the full spectrum of disease. With continued advancements in medical research and medical technology, the biological medicines sector face new challenges - not just scientific and regulatory.
The National Institute for Biological Standards and Control (NIBSC) is a global leader in the field of biological standardisation. It is responsible for developing and producing over 90% of the International Standards in use around the world that assure the quality of biological medicines. Our challenge for the 21st Century is to encourage and support innovation of biological products, whilst, at the same time, ensuring high levels of safety and quality.
NIBSC will continue its rich tradition of melding strong scientific research, with shaping innovative regulation that ensure timely access to safe and effective biological products.
The event will be held at The Royal College of Obstetricians and Gynaecologists
Why attend?
Expected attendance of 200+ delegates from the biological medicines sector in the UK and abroadLearn about the latest strategic and technical developments taking place in biological medicines and gain insight into the regulatory challenge that they pose
Network and take the opportunity to meet key contacts, build relationships and initiate collaborations
Help shape the future of the new biological medicines regulation.
Scientific themes of the event include:
Monoclonal antibodies: the future of biological therapiesMolecular pathology and precision medicines: the importance of getting it right!
Keeping the vaccine pipeline open: high quality products at affordable prices
Advanced therapies: delivering the promise.
Who should attend?
This is must attend event for those who wish to help shape the future agenda of regulatory science for biological medicines.The symposium will bring together world class leaders from:
Biologics manufacturers
Academics and Innovators
National and International Regulators and public health organisations
Policy makers and funding agencies.
